Xtl Biopharmaceuticals (XTLB) Cash & Equivalents (2009 - 2025)
Xtl Biopharmaceuticals' Cash & Equivalents came in at $76,000 for the quarter ended Dec 31, 2025, down 79.5% from $371,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Cash & Equivalents (2009 - 2025) Analysis & Trends
Going back to the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Cash & Equivalents data covers 65 quarters.
- Cash & Equivalents has declined in each of the last five years, with a five-year compound annual growth rate of -55.7% (years ended Dec 2020 to Dec 2025).
- Going back by year, Cash & Equivalents was $371,000 in the year ended Dec 31, 2024 (-82.3%), $2.09 million in the year ended Dec 31, 2023 (-29.5%), $2.97 million in the year ended Dec 31, 2022 (-18.2%) and $3.63 million in the year ended Dec 31, 2021 (-18.5%).
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Cash & Equivalents in data going back to the quarter ended Mar 31, 2009.
- Across the past five years, year-over-year decline in Cash & Equivalents ran from 17.7% in the quarter ended Mar 31, 2022 to 79.5% in the quarter ended Dec 31, 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Xtl Biopharmaceuticals | 2.27 Bn | 2.27 Bn | - | 76,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 76,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Dec 31, 2024 | 371,000.00 |
| Sep 30, 2024 | 820,000.00 |
| Jun 30, 2024 | 594,000.00 |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 1.90 Mn |
| Dec 31, 2022 | 2.09 Mn |
| Sep 30, 2022 | 2.23 Mn |
| Jun 30, 2022 | 2.35 Mn |
| Mar 31, 2022 | 2.79 Mn |
| Dec 31, 2021 | 2.97 Mn |
| Sep 30, 2021 | 3.01 Mn |
| Jun 30, 2021 | 2.92 Mn |
| Mar 31, 2021 | 3.39 Mn |
| Dec 31, 2020 | 3.63 Mn |
| Sep 30, 2020 | 3.75 Mn |
API Access
Xtl Biopharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();